Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-16-004727
Filing Date
2016-01-07
Accepted
2016-01-06 17:53:36
Documents
51
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cannabics_10k-083115.htm 10-K 417771
2 CERTIFICATION cannabics_10k-ex3101.htm EX-31.1 11499
3 CERTIFICATION cannabics_10k-ex3102.htm EX-31.2 11247
4 CERTIFICATION cannabics_10k-ex3201.htm EX-32.1 4502
5 CERTIFICATION cannabics_10k-ex3202.htm EX-32.2 4556
6 GRAPHIC image_003.jpg GRAPHIC 3565
7 GRAPHIC image_004.jpg GRAPHIC 3519
  Complete submission text file 0001019687-16-004727.txt   1743461

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cnbx-20140831.xml EX-101.INS 186125
9 XBRL SCHEMA FILE cnbx-20140831.xsd EX-101.SCH 20270
10 XBRL CALCULATION FILE cnbx-20140831_cal.xml EX-101.CAL 35678
11 XBRL DEFINITION FILE cnbx-20140831_def.xml EX-101.DEF 47514
12 XBRL LABEL FILE cnbx-20140831_lab.xml EX-101.LAB 145073
13 XBRL PRESENTATION FILE cnbx-20140831_pre.xml EX-101.PRE 117822
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 161328002
SIC: 1000 Metal Mining